Background As the need for transplantable organs increases, waiting lists of patients
become longer. We studied the size and composition of the national pool of brain-dead …

Background. In a recent single-center study, donor use of catecholamines was identified to
reduce kidney allograft rejection. This study investigates the effects of donor employment of …

PURPOSE: Corticosteroids are used to promote hemodynamic stability and reduce
inflammatory organ injury after brain death. High-dose (HD) methylprednisolone has …

BACKGROUND: Hormonal resuscitation therapy (HRT) has been shown to increase the
number of organs available for transplant. Likewise, optimal fluid balance, as measured by …

As of August 2007, 96 900 people are awaiting organ transplantation in the United States,
while only 28 930 transplants were performed in 2006. With such a large gap between …

Transplantation has evolved as the treatment of choice for many patients with end-stage
organ disease. However, despite the> 80% one-year functional survival rate of most …

BACKGROUND: Hormone replacement therapy increases the number and quality of grafts
recovered from brain-dead organ donors. Arginine vasopressin (AVP) has also been shown …

Objectives: To review all published clinical studies of thyroid hormone administration to
brain-dead potential organ donors. Methods: A search of PubMed using multiple search …

In a prospective study, we documented the hemodynamic effects of conventional donor
maintenance in 24 brain-dead organ donors. Patients were then randomized to receive …

Over the past two decades, the demand for donor organs continues to outpace the number
of organs available for transplantation. Parallel with this has been a change in the …